Citation Impact
Citing Papers
Complement Factor H Polymorphism and Age-Related Macular Degeneration
2005 StandoutScience
Effect of C1 Inhibitor on Inflammatory and Physiologic Response Patterns in Primates Suffering from Lethal Septic Shock
1998
Hypoxia, a Novel Inducer of Acute Phase Gene Expression in a Human Hepatoma Cell Line
1995
Potential Mechanisms for a Proinflammatory Vascular Cytokine Response to Coagulation Activation
1998
Inflammation and Alzheimer's disease
2000 Standout
Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal Subjects
1990
Structure of the TRPA1 ion channel suggests regulatory mechanisms
2015 StandoutNatureNobel
The pentraxins: possible role in Alzheimer's disease and other innate inflammatory diseases
2001
Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?
2000
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
2020 Standout
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease
1999 Standout
Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease
1999
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
2012 StandoutNature
The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
1997
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration
1999
Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis
2009 Standout
Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes
2005 Standout
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia.
1996
Cytokines Associated with Amyloid Plaques in Alzheimer's Disease Brain Stimulate Human Glial and Neuronal Cell Cultures to Secrete Early Complement Proteins, But Not C1-Inhibitor
1999
Regulation of complement activation by C-reactive protein
1999
Inflammation and coagulation
2010
Severe Sepsis and Septic Shock
2013 Standout
Oxygen Free Radicals and Brain Dysfunction
1991
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Thrombin signalling and protease-activated receptors
2000 StandoutNature
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Modulators of coagulation. A critical appraisal of their role in sepsis
1992
Yin and Yang: complement activation and regulation in Alzheimer’s disease
2003
Expression of complement C4 and C9 genes by human astrocytes
1998
Coagulation disorders in septic shock
1993
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
The Immunopathogenesis of Sepsis in Elderly Patients
2005
The role of exercise and PGC1α in inflammation and chronic disease
2008 Nature
Localization and Cell Association of C1q in Alzheimer's Disease Brain
1996
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
1994
Apoptosis
2002 Standout
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo
2000
Alzheimer's Disease
2010 Standout
Complement
2001 Standout
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
The Pathophysiology and Treatment of Sepsis
2003 Standout
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
2001 Standout
Disseminated Intravascular Coagulation
1999 Standout
Points of control in inflammation
2002 StandoutNature
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis
2001 Standout
Inflammation, Aspirin, and the Risk of Cardiovascular Disease in Apparently Healthy Men
1997 Standout
Expression and regulation of complement C1q by human THP-1-derived macrophages
1998
Tumour necrosis factor and Crohn's disease.
1997
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
The inflammatory reflex
2002 StandoutNature
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T‐lymphocytes and preserved MHC class I antigen expression
2008
Atherosclerosis
2001 Standout
Serum Procalcitonin and C-Reactive Protein Levels as Markers of Bacterial Infection: A Systematic Review and Meta-analysis
2004 Standout
Frailty in elderly people
2013 Standout
Molecular and Cellular Characterization of the Membrane Attack Complex, C5b-9, in Alzheimer’s Disease
1997
Biochemical and functional characterization of the interaction between pentraxin 3 and C1q
2003
Intensive Insulin Therapy in the Medical ICU
2006 Standout
Associations of elevated Interleukin-6 and C-Reactive protein levels with mortality in the elderly
1999
The immunopathogenesis of sepsis
2002 StandoutNature
NSAIDS inhibit the IL-1β-induced IL-6 release from human post-mortem astrocytes: the involvement of prostaglandin E2
1997
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease
1999
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Serpin Structure, Mechanism, and Function
2002 Standout
C-Reactive Protein Frequently Colocalizes With the Terminal Complement Complex in the Intima of Early Atherosclerotic Lesions of Human Coronary Arteries
1998
Tirzepatide Once Weekly for the Treatment of Obesity
2022 Standout
Interleukin-6 Stimulates Coagulation, not Fibrinolysis, in Humans
1996
INFLAMMATION AND ALZHEIMERS DISEASE
2000
Intensive Insulin Therapy Exerts Antiinflammatory Effects in Critically Ill Patients and Counteracts the Adverse Effect of Low Mannose-Binding Lectin Levels
2003
Enhanced Inflammatory Response to Coronary Angioplasty in Patients With Severe Unstable Angina
1998
Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.
1994
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
1997 StandoutScience
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
2001 StandoutScience
American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines For Medical Care of Patients with Obesity
2016
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
2000 Standout
Once-Weekly Semaglutide in Adults with Overweight or Obesity
2021 Standout
Double-knockout mice for α- and β-synucleins: Effect on synaptic functions
2004 StandoutNobel
Regional manifestations and control of the immune system
2002
Cysteine-Mediated Redox Signaling: Chemistry, Biology, and Tools for Discovery
2013
Interleukin-10 Inhibits Activation of Coagulation and Fibrinolysis During Human Endotoxemia
1997
Coagulation and inflammation
2001
Inflammatory mechanisms in Alzheimer's disease: implications for therapy
1994
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.
1993
Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy Men
2000 Standout
Increasing Burden of Cardiovascular Disease
1998
Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1
2000
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1
1996 StandoutNobel
Elevated Levels of Interleukin-6 in Unstable Angina
1996
The Pathophysiologic Roles of Interleukin-6 in Human Disease
1998
Disseminated Intravascular Coagulation
1999
Pathogenesis of DIC in Sepsis
1999
Tumor Necrosis Factor-Dependent Adhesions as a Major Protective Mechanism Early in Septic Peritonitis in Mice
2001
Sepsis: Multiple Abnormalities, Heterogeneous Responses, and Evolving Understanding
2013
Inhibition of complement activation by IgG4 antibodies.
1986
Works of C.E. Hack being referenced
Ischemia induces nuclear NOX2 expression in cardiomyocytes and subsequently activates apoptosis
2006
Inflammatory markers in late-life depression: Results from a population-based study
2007
Interactions between Oxygen Free Radicals and ProteinsImplications for Rheumatoid Arthritis. An Overview
1989
Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2.
2001
Localisation of C reactive protein in infarcted tissue sites of multiple organs during sepsis
2002
Complement C1-inhibitor expression in Alzheimer's disease
1998
Application of a monoclonal antibody against a neoepitope on activated C4 in an ELISA for the quantification of complement activation via the classical pathway
1993
The distortive mechanism for the activation of complement component C1 supported by studies with a monoclonal antibody against the “arms” of C1q
1988
A model for the interplay of inflammatory mediators in sepsis —a study in 48 patients
1990
Early complement components in Alzheimer's disease brains
1995
Distribution pattern and functional state of complement proteins and α-antichymotrypsin in cerebral β/A4 deposits in Alzheimer's disease
1992
CRP-mediated activation of complement in vivo: assessment by measuring circulating complement-C-reactive protein complexes.
1996
Characterization of recombinant C1 inhibitor P1 variants.
1992
The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)
1999
Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood
1995
Detection of Activation of the Contact System of Coagulation In Vitro and In Vivo: Quantitation of Activated Hageman Factor-C1-Inhibitor and Kallikrein-C1-Inhibitor Complexes by Specific Radioimmunoassays
1987
Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
1997
Effect of hypertriglyceridemia on endotoxin responsiveness in humans
1995
Quantification of Functional and Inactivated α2-Macroglobulin in Sepsis
1991
Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component
1996
A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo.
1981
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.
1994
Biosynthesis of normal and low-molecular-mass complement component C1q by cultured human monocytes and macrophages
1989
Fibrinolytic response to tumor necrosis factor in healthy subjects.
1991
Longstanding Obliterative Panarteritis in Kawasaki Disease: Lack of Cyclosporin A Effect
2003
Circulating inflammatory mediators predict shock and mortality in febrile patients with microbial infection
2003
A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
1992
Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees
1995